Inventor · disambiguated record
Zhifang Chen
Also filed as: CHEN ZHIFANG
14 granted patents·2 pending applications·54 citations·filing 2009–2022
88Inventor score
Files withSHANGHAI FOCHON PHARMACEUTICAL CO LTD6FOCHON PHARMACEUTICALS LTD5CHEN ZHIFANG1CHONGQING FOCHON PHARMACEUTICAL CO LTD1UNIV BEIJING NORMAL1
Top patents by PatentIndex Score
16 records- 0191USD977594SToy water gunYONGKANG STAR DIAMOND IND AND TRADE CO LTD·Filed 2022·Granted Feb 7, 2023·25 cites·1 claims
- 0290US9957172B2Method for removing perfluorinated compounds by concentration and separationUNIV BEIJING NORMAL·Filed 2014·Granted May 1, 2018·12 cites·17 claims
- 0387US11053239B2Compounds as BLC-2-selective apoptosis-inducing agentsFOCHON PHARMACEUTICALS LTD·Filed 2018·Granted Jul 6, 2021·6 cites·13 claims
- 0478US11091478B2Apoptosis-inducing agentsFOCHON PHARMACEUTICALS LTD·Filed 2018·Granted Aug 17, 2021·2 cites·32 claims
- 0578US10641460B1Lampshade and lampCHEN ZHIFANG·Filed 2019·Granted May 5, 2020·4 cites·18 claims
- 0673US10087195B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 2, 2018·2 cites·14 claims
- 0771US9556171B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2014·Granted Jan 31, 2017·2 cites·15 claims
- 0860US12312349B2Apoptosis-inducing agentsFOCHON PHARMACEUTICALS LTD·Filed 2021·Granted May 27, 2025·0 cites·16 claims
- 0951US2023159527A1Compounds as bcl-2 inhibitorsFOCHON PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1049US2022354860A1Heterocyclic derivatives and use thereofFOCHON PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1146US10835535B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 17, 2020·0 cites·17 claims
- 1246US8286368B2Method and apparatus for rationalizing the allocation of heat energy generated from catalytic combustion process for enameling machineYE ZHIDE·Filed 2009·Granted Oct 16, 2012·1 cites·9 claims
- 1345US10022374B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Jul 17, 2018·0 cites·13 claims
- 1439US11168078B2Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenaseSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 9, 2021·0 cites·17 claims
- 1537US10800785B2Substituted pyrrolo[2,3-d]pyridazin-4-ones and pyrazolo[3,4-d]pyridazin-4-ones as protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Oct 13, 2020·0 cites·18 claims
- 1634US10450316B2Certain protein kinase inhibitorCHONGQING FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 22, 2019·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Zhifang Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →